Agilent Technologies, Inc. [NYSE:A]: Analyst Rating and Earnings
Pro stock market traders often keep their attention pointed at what top market analysts have to say regarding a potential equity investment. For Agilent Technologies, Inc. [A] currently, the latest-available mean analyst rating is for the fiscal quarter that will end in October. On average, stock market experts give A an Outperform rating. Its stock price has been found in the range of 60.42 to 82.27. This is compared to its latest closing price of $80.40.
Wall Street analysts provide their ratings on a scale of 1 to 5, and the current average score for Agilent Technologies, Inc. [A] is sitting at 1.57. This is compared to 1 month ago, when its average rating was 1.71.
For the quarter ending in Jan-19 Agilent Technologies, Inc. [A] generated $1.28 billion in sales. That’s 0.96% higher than the average estimate of $1.27 billion as provided by Wall Street analysts. The three indicators above suggest that overall, this stock is demonstrating a mixed bag of positive appeal and some drawbacks, making it a somewhat risky investment that also has the potential to generate high ROI in the long run.
Keep your eyes peeled for this company’s upcoming financial results publication, which is slated for Mon 13 May (In 27 Days).
Fundamental Analysis of Agilent Technologies, Inc. [A]
Now let’s turn to look at profitability: with a current Operating Margin for Agilent Technologies, Inc. [A] sitting at +18.95 and its Gross Margin at +54.74, this company’s Net Margin is now 22.90%. These measurements indicate that Agilent Technologies, Inc. [A] is generating considerably more profit, after expenses are accounted for, compared to its market peers.
This company’s Return on Total Capital is 14.09, and its Return on Invested Capital has reached 13.60%. Its Return on Equity is 6.72, and its Return on Assets is 3.72. These metrics all suggest that Agilent Technologies, Inc. is doing well at using the money it earns to generate returns.
Turning to investigate this organization’s capital structure, Agilent Technologies, Inc. [A] has generated a Total Debt to Total Equity ratio of 39.39. Similarly, its Total Debt to Total Capital is 28.26, while its Total Debt to Total Assets stands at 21.06. Looking toward the future, this publicly-traded company’s Long-Term Debt to Equity is 39.39, and its Long-Term Debt to Total Capital is 28.26.
What about valuation? This company’s Enterprise Value to EBITDA is 22.28 and its Total Debt to EBITDA Value is 1.58. The Enterprise Value to Sales for this firm is now 5.10, and its Total Debt to Enterprise Value stands at 0.09. Agilent Technologies, Inc. [A] has a Price to Book Ratio of 4.51, a Price to Cash Flow Ratio of 19.37 and P/E Ratio of 21.96. These metrics show that this company has a mixed appeal, and ROI could be a gain or a loss.
Shifting the focus to workforce efficiency, Agilent Technologies, Inc. [A] earns $332,027 for each employee under its payroll. Similarly, this company’s Receivables Turnover is 6.01 and its Total Asset Turnover is 0.58. This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 2.74 and its Current Ratio is 3.29. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.
Agilent Technologies, Inc. [A] has 318.00M shares outstanding, amounting to a total market cap of $24.66B. Its stock price has been found in the range of 60.42 to 82.27. At its current price, it has moved by -5.74% from its 52-week high, and it has moved 28.35% from its 52-week low.
This stock’s Beta value is currently 1.39, which indicates that it is more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 37.14. This RSI score is good, suggesting this stock is neither overbought or oversold.
Conclusion: Is Agilent Technologies, Inc. [A] a Reliable Buy?
Shares of Agilent Technologies, Inc. [A], on the whole, present investors with both positive and negative signals. Wall Street analysts have mixed reviews when it comes to the 12-month price outlook, and this company’s financials show a combination of strengths and weaknesses. Based on the price performance, this investment is somewhat risky while presenting reasonable potential for ROI.